烧伤患者静脉血栓栓塞:风险被低估且预防剂量不足?
该研究分两部分:回顾2013-2018年VABS收治的1475例烧伤患者,VTE发生率为1.36%;并前瞻性检测20例>10% TBSA烧伤患者的抗Xa因子水平。结果显示当前依诺肝素预防方案难以达到预防性抗Xa水平,提示需评估不同给药方案。
要点
- 烧伤患者VTE发生率为1.36%,ICU入住和机械通气与VTE风险显著相关。
- 当前依诺肝素预防方案下,仅50%患者后续达到预防性抗Xa峰值水平。
- 所有检测患者 trough 抗Xa水平均未达到预防阈值,提示剂量不足。
核心结论
- VABS烧伤患者VTE发生率较高,尤其重症烧伤患者,当前血栓预防方案无法有效达到预防性抗Xa水平。
- 证据提示需评估烧伤患者不同给药方案以改善抗Xa水平,降低高危患者VTE发生率。
研究设计与样本
- 第一部分为回顾性研究,审查BRANZ登记中2013-2018年VABS收治的烧伤患者VTE病例,共1475例。
- 第二部分为前瞻性研究,纳入20例>10% TBSA烧伤患者,测定依诺肝素峰值和谷值抗Xa因子水平。
主要发现
- 1475例中发生20例VTE,发生率为1.36%。
- 烧伤%TBSA(OR=1.04,95%CI:1.03-1.06)、全层烧伤(OR=2.78,95%CI:1.15-6.73)、ICU入住(OR=15.08,95%CI:5.01-45.44)、机械通气(OR=10.62,95%CI:4.05-27.91)、手术操作(OR=1.43,95%CI:1.29-1.59)和较长住院时间(OR=1.05,95%CI:1.04-1.07)均与VTE风险增加相关。
- 20例前瞻性参与者中,15%初始预防性峰值抗Xa水平在参考范围内;后续测量中50%参与者达到预防性峰值抗Xa水平。
- 17例检测谷值抗Xa水平,无参与者初始或后续谷值抗Xa水平达到或超过预防阈值。
临床怎么用
- 对烧伤患者,尤其合并ICU入住、机械通气、全层烧伤等高危因素者,应警惕VTE风险。
- 当前标准剂量依诺肝素预防可能不足,可考虑监测抗Xa因子水平并评估调整剂量方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Burns patients exhibit all factors of Virchow's triad and are thus at high theoretical risk of venous thromboembolism (VTE). At our tertiary referral burns unit, a standard dose of low molecular weight heparin, which acts primarily by inhibiting Factor Xa, is given for thromboprophylaxis. However, the pharmacokinetics of enoxaparin are altered following a burn injury, and thus burns patients are likely underdosed on their thromboprophylaxis. The objectives of this study were to determine the incidence and risk factors for VTE among burns patients at the Victorian Adult Burns Service (VABS) and to determine the adequacy of the current enoxaparin thromboprophylaxis regimen through measurement of anti-factor Xa (AFXa) levels and comparison with established reference ranges. METHODS: This study consisted of two parts. In part 1, the Burns Registry of Australia and New Zealand (BRANZ) was reviewed for cases of VTE in burns patients admitted to the VABS from 2013 - 2018. Part 2 was a prospective study that determined peak and trough AFXa levels in patients admitted to the VABS with >10% total body surface area (TBSA) burns. RESULTS: Part 1. Totally, 1,475 patients were admitted to the VABS between 2013 - 2018. There were 20 cases of VTE (1.36%). Percent TBSA of burn (OR = 1.04, 95% CI: 1.03 - 1.06), full thickness burns (OR = 2.78, 95% CI: 1.15 - 6.73), ICU admission (OR = 15.08, 95% CI: 5.01 - 45.44), mechanical ventilation (OR = 10.62, 95% CI: 4.05 - 27.91), operative procedures (OR = 1.43, 95% CI: 1.29 - 1.59), and a longer hospital stay (OR = 1.05, 95% CI: 1.04 - 1.07) were all associated with an increased VTE risk. Part 2. A total of 20 participants with >10% TBSA burns were recruited to the prospective study. Peak anti Factor Xa (AFXa) levels were measured for all 20 participants with 15% recording an initial prophylactic peak AFXa level within reference range. Upon subsequent measurements, 50% of participants reached a prophylactic peak AFXa level. Trough AFXa levels were measured for 17 participants with no participant recording an initial or subsequent trough AFXa level at or above the prophylactic threshold. CONCLUSION: Our study demonstrates a high incidence of VTE among burns patients at the VABS, especially among the major burns patients, and a thromboprophylaxis protocol that is ineffective in achieving prophylactic levels of AFXa level. The evidence suggests a need to evaluate different dosing protocols among burns patients in order to improve AFXa levels, with the aim of decreasing incidence of VTE in high-risk patients.
引用
- Lu P, Harms KA, Paul E, et al. Venous thromboembolism in burns patients: Are we underestimating the risk and underdosing our prophylaxis? J Plast Reconstr Aesthet Surg. 2020. PMID: 33414092. doi:10.1016/j.bjps.2020.12.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。